Inventor · disambiguated record
Jianhua Chao
Also filed as: CHAO JIANHUA
28 granted patents·18 pending applications·146 citations·filing 2002–2024
95Inventor score
Top patents by PatentIndex Score
46 records- 0194US11155549B2Ester and carbonate pyrimidine compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Oct 26, 2021·5 cites·26 claims
- 0294US7132445B23,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Nov 7, 2006·58 cites·82 claims
- 0391US10793568B2Hormone receptor modulators for treating metabolic conditions and disordersARDELYX INC·Filed 2017·Granted Oct 6, 2020·4 cites·1 claims
- 0488US7964646B23,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2006·Granted Jun 21, 2011·10 cites·47 claims
- 0588US7947720B23,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2009·Granted May 24, 2011·10 cites·4 claims
- 0685US2025115608A1Hormone receptor modulators for treating metabolic conditions and disordersARDELYX INC·Filed 2024·Application pending·0 cites
- 0784US9850206B2S1P and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Dec 26, 2017·4 cites·22 claims
- 0884US6878709B23,4-di-substituted pyridazinediones as CXC chemokine receptor antagonistsSCHERING CORP·Filed 2003·Granted Apr 12, 2005·20 cites·4 claims
- 0983US7326729B2CXCR1 and CXCR2 chemokine antagonistsSCHERING CORP·Filed 2005·Granted Feb 5, 2008·6 cites·13 claims
- 1081US8383818B2Functionally selective alpha2C adrenoreceptor agonistsMERCK SHARP & DOHME·Filed 2009·Granted Feb 26, 2013·5 cites·4 claims
- 1180US11091482B2Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activatorsARDELYX INC·Filed 2017·Granted Aug 17, 2021·3 cites·1 claims
- 1279US7960433B2Treatment of chemokine mediated diseasesSCHERING CORP·Filed 2007·Granted Jun 14, 2011·4 cites·11 claims
- 1379US7846946B2Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonistsSCHERING PLOUGH CORP·Filed 2009·Granted Dec 7, 2010·3 cites·2 claims
- 1478US7691856B2Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligandsSCHERING CORP·Filed 2007·Granted Apr 6, 2010·3 cites·67 claims
- 1577US12209088B2Hormone receptor modulators for treating metabolic conditions and disordersARDELYX INC·Filed 2022·Granted Jan 28, 2025·0 cites·20 claims
- 1675US7635705B2Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonistsSCHERING CORP·Filed 2006·Granted Dec 22, 2009·2 cites·19 claims
- 1770US11845747B2Ester and carbonate pyrimidine compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Dec 19, 2023·0 cites·17 claims
- 1870US7338968B2Thiadiazoles AS CXC- and CC- chemokine receptor ligandsSCHERING CORP·Filed 2004·Granted Mar 4, 2008·4 cites·46 claims
- 1969US7671212B2Isothiazole dioxides as CXC- and CC-chemokine receptor ligandsSCHERING CORP·Filed 2004·Granted Mar 2, 2010·4 cites·39 claims
- 2068US2021017177A1Hormone receptor modulators for treating metabolic conditions and disordersARDELYX INC·Filed 2020·Application pending·0 cites
- 2166US8324213B2Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulatorsMCCORMICK KEVIN D·Filed 2009·Granted Dec 4, 2012·1 cites·11 claims
- 2263US11718619B2Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activatorsARDELYX INC·Filed 2021·Granted Aug 8, 2023·0 cites·4 claims
- 2363US2025388568A1Nlrp3 inhibitorsKODIAK SCIENCES INC·Filed 2023·Application pending·0 cites
- 2457US10399924B2Deuterium substituted fumarate derivativesBIOGEN MA INC·Filed 2014·Granted Sep 3, 2019·0 cites·29 claims
- 2556US7786149B2Thiadiazoles as CXC- and CC- chemokine receptor ligandsSCHERING CORP·Filed 2007·Granted Aug 31, 2010·0 cites·19 claims
- 2655US9421273B2Silicon-containing fumaric acid estersBIOGEN IDEC INC·Filed 2012·Granted Aug 23, 2016·0 cites·8 claims
- 2755US8569312B2Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2013·Granted Oct 29, 2013·0 cites·11 claims
- 2854US8476274B2Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2012·Granted Jul 2, 2013·0 cites·10 claims
- 2953US2007248594A1Cxcr1 and cxcr2 chemokine antagonistsSCHERING CORP·Filed 2007·Application pending·0 cites
- 3053US2011213029A13,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor LigandsSCHERING CORP·Filed 2011·Application pending·0 cites
- 3152US2014179779A1Deuterium Substituted Fumarate DerivativesBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 3252US2023406803A1Tropolone derivatives and tautomers thereof for iron regulation in animalsKINESID THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3352US2004106794A13,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2002·Application pending·0 cites
- 3451US2010249098A1Oxypiperidine derivatives and methods of use thereofSCHERING CORP·Filed 2008·Application pending·0 cites
- 3550US8470863B2Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonistsZHENG JUNYING·Filed 2008·Granted Jun 25, 2013·0 cites·14 claims
- 3650US2024018105A1Tropolone derivatives and tautomers thereof for iron regulation in animalsKINESID THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3749US2004186142A1Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligandsSCHERING CORP PHARMACOPEIA INC·Filed 2003·Application pending·0 cites
- 3849US2012028940A1Functionally selective azanitrile alpha-2c adrenoreceptor agonistsBOYCE CHRISTOPHER W·Filed 2009·Application pending·0 cites
- 3947US11439641B2Pyrimidine JAK inhibitors for the treatment of skin diseasesTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Sep 13, 2022·0 cites·31 claims
- 4047US2004053953A1Treatment of chemokine mediated diseasesSCHERING CORP·Filed 2003·Application pending·0 cites
- 4146US2011166124A1Tricyclic spirocycle derivatives and methods of useMCCORMICK KEVIN D·Filed 2009·Application pending·0 cites
- 4244US11753410B2Hormone receptor modulators for treating metabolic mutagenic and fibrotic conditions and disordersARDELYX INC·Filed 2018·Granted Sep 12, 2023·0 cites·19 claims
- 4343US2008045489A13,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligandsCHAO JIANHUA·Filed 2007·Application pending·0 cites
- 4435US2004097547A13,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsFiled 2002·Application pending·0 cites
- 4533US2017354639A1Diterpenoid derivatives and methods of use thereofBIOGEN MA INC·Filed 2015·Application pending·0 cites
- 4632US2013079271A1Reversed biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulatorsMCCORMICK KEVIN D·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jianhua Chao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →